- Home
- KRNT vs AUPH Comparison
KRNT vs AUPH Comparison
Compare KRNT & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNT
- AUPH
- Stock Information
- Founded
- KRNT 2002
- AUPH 1993
- Country
- KRNT Israel
- AUPH Canada
- Employees
- KRNT N/A
- AUPH N/A
- Industry
- KRNT Industrial Machinery/Components
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- KRNT Industrials
- AUPH Health Care
- Exchange
- KRNT Nasdaq
- AUPH Nasdaq
- Market Cap
- KRNT 1.4B
- AUPH 1.1B
- IPO Year
- KRNT 2015
- AUPH 1999
- Fundamental
- Price
- KRNT $21.34
- AUPH $8.15
- Analyst Decision
- KRNT Strong Buy
- AUPH Strong Buy
- Analyst Count
- KRNT 5
- AUPH 2
- Target Price
- KRNT $34.00
- AUPH $11.50
- AVG Volume (30 Days)
- KRNT 374.7K
- AUPH 1.7M
- Earning Date
- KRNT 05-07-2025
- AUPH 05-01-2025
- Dividend Yield
- KRNT N/A
- AUPH N/A
- EPS Growth
- KRNT N/A
- AUPH N/A
- EPS
- KRNT N/A
- AUPH 0.04
- Revenue
- KRNT $203,825,000.00
- AUPH $235,133,000.00
- Revenue This Year
- KRNT $11.22
- AUPH $13.80
- Revenue Next Year
- KRNT $12.76
- AUPH $24.57
- P/E Ratio
- KRNT N/A
- AUPH $203.13
- Revenue Growth
- KRNT N/A
- AUPH 33.97
- 52 Week Low
- KRNT $13.59
- AUPH $4.71
- 52 Week High
- KRNT $34.29
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- KRNT 26.01
- AUPH 51.32
- Support Level
- KRNT $19.53
- AUPH $7.92
- Resistance Level
- KRNT $23.88
- AUPH $8.85
- Average True Range (ATR)
- KRNT 1.30
- AUPH 0.42
- MACD
- KRNT -0.27
- AUPH 0.04
- Stochastic Oscillator
- KRNT 27.34
- AUPH 69.72
About KRNT Kornit Digital Ltd.
Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.